Julie Prettyman, Lauren Engel, D. Boldt‐Houle, S. Atkinson, Wanda Wilt
{"title":"Personalizing Treatment In the Delivery of Care by Nurses To Patients with Prostate Cancer","authors":"Julie Prettyman, Lauren Engel, D. Boldt‐Houle, S. Atkinson, Wanda Wilt","doi":"10.7257/1053-816X.2019.39.2.83","DOIUrl":null,"url":null,"abstract":"&NA; New therapies and evolving scientific concepts are significantly improving outcomes for patients with prostate cancer. A greater emphasis on delivering state‐of‐the‐art nursing care and personalization of treatments is needed. Nurses often spend significant time with patients, caregivers, and their families, and develop personal relationships that present opportunities for enhanced education of treatment options that may reflect patients' lifestyles and personal preferences. Newer drugs are costly, and their use should be discussed with the patient in regard to choice of treatment, potential survival benefits, and overall quality‐of‐life outcomes.","PeriodicalId":85039,"journal":{"name":"Journal of urological nursing","volume":"39 1","pages":"83–99"},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of urological nursing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7257/1053-816X.2019.39.2.83","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
Abstract
&NA; New therapies and evolving scientific concepts are significantly improving outcomes for patients with prostate cancer. A greater emphasis on delivering state‐of‐the‐art nursing care and personalization of treatments is needed. Nurses often spend significant time with patients, caregivers, and their families, and develop personal relationships that present opportunities for enhanced education of treatment options that may reflect patients' lifestyles and personal preferences. Newer drugs are costly, and their use should be discussed with the patient in regard to choice of treatment, potential survival benefits, and overall quality‐of‐life outcomes.